Thoracic and Cardiovascular Surgeon最新文献_第2页

Comparison of Long-Term Performance of Porcine versus Pericardial Bioprostheses. 猪与心包生物假体的长期性能比较。

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-04-01 Epub Date: 2025-01-07 DOI: 10.1055/a-2505-8447

Amedeo Anselmi, Morgan Daniel, Marie Aymami, Celine Chabanne, Sebastien Rosier, Julien Mancini, Jean Philippe Verhoye

{"title":"Comparison of Long-Term Performance of Porcine versus Pericardial Bioprostheses.","authors":"Amedeo Anselmi, Morgan Daniel, Marie Aymami, Celine Chabanne, Sebastien Rosier, Julien Mancini, Jean Philippe Verhoye","doi":"10.1055/a-2505-8447","DOIUrl":"10.1055/a-2505-8447","url":null,"abstract":"The long-term comparative results between porcine and pericardial bioprostheses for surgical aortic valve replacement (SAVR) are debated. Scarce information exists concerning direct comparative evaluation among contemporary devices. We compared late and very late results in a single center series (n = 3,983 cases).From a prospectively collected database we included 3,983 recipients of two current porcine bioprostheses (porcine group) or one current pericardial bioprosthesis (pericardial group). We evaluated the long-term freedom from structural valve deterioration (SVD) with both Kaplan-Meier and competing risk methods (primary endpoint). We distinguished between SVD and patient-prosthesis mismatch (PPM). Secondary endpoints were late survival, freedom from valve-related mortality, freedom from reoperation for SVD, freedom from nonstructural valve dysfunction (NSVD) and freedom from endocarditis.Median follow-up was 10.4 years (99.7% complete, 32,219 patients/years). Overall survival was significantly lower in the porcine group (p = 0.002), related to baseline intergroup differences. At 10 years, Kaplan-Meier freedom from SVD was significantly better in the porcine group (98.0% ± 0.3 vs. 96.3% ± 0.8; p = 0.003). Competing risk freedom from SVD at 10 years was 98.6% ± 0.2 and 97.2% ± 0.6 (porcine and pericardial group, respectively; p = 0.001). The porcine group displayed a higher rate of PPM.Despite the augmented risk of PPM compared with pericardial valves, in this series porcine bioprostheses seem to perform better concerning protection from late (>10 years) SVD. Smaller valve sizes (19-21 mm) may negatively impact the SVD risk among porcine valves but not among pericardial valves. These elements need to be considered for valve choice and surgical strategy in SAVR candidates according to their life expectancy, clinical context, and annulus size.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":"181-190"},"PeriodicalIF":1.4,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effect of Balloon Dilatation and Stent Implantation in Iliac Vein Compression Syndrome. 球囊扩张和支架植入对髂静脉压迫综合征的影响

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-04-01 Epub Date: 2025-02-14 DOI: 10.1055/a-2496-5378

Sen Yang, Jian Zhao, Peng Hou, Yan Gu

{"title":"Effect of Balloon Dilatation and Stent Implantation in Iliac Vein Compression Syndrome.","authors":"Sen Yang, Jian Zhao, Peng Hou, Yan Gu","doi":"10.1055/a-2496-5378","DOIUrl":"10.1055/a-2496-5378","url":null,"abstract":"To investigate the efficacy of balloon dilatation combined with stent implantation in the treatment of iliac vein compression syndrome (IVCS).This research was a retrospective study that enrolled 127 IVCS patients for clinical data. The patients were divided into percutaneous transluminal angioplasty (PTA) group (n = 63) and stent implantation group (n = 64). The PTA group was treated with iliac vein balloon dilatation, and the stent implantation group was treated with combined stent implantation based on the PTA group. In both the groups, the quality of life was assessed using Chronic Venous Insufficiency Quality of Life Questionnaire (CIVIQ); complications occurring during the perioperative period and at postoperative follow-up were recorded; the vascular patency rate was calculated, and patient's condition was evaluated using the Villalta scale.The stent implantation group exhibited lower postoperative CIVIQ scores than the PTA group, and the stent implantation group (4.60%) had lower complication rate than the PTA group (19.05%). At 2 years of follow-up, the stent implantation group (92.19%) had higher vascular patency rate than the PTA group (79.37%). Villalta scores were lower in the stent implantation group than in the PTA group at 6, 12, and 24 months postoperatively.Iliac vein balloon dilatation combined with stent implantation for the treatment of IVCS can improve vessel patency rates, alleviate patients' clinical symptoms, and enhance their quality of life.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":"247-252"},"PeriodicalIF":1.4,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143426220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prone Positioning for Acute Respiratory Failure after PEA: An Initial Experience. 俯卧位治疗PEA后急性呼吸衰竭的初步经验。

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-04-01 Epub Date: 2024-12-24 DOI: 10.1055/a-2508-0644

Koray Ak, Majd Tarazi, Fatih Öztürk, Şehnaz Olgun Yıldızeli, Alper Kararmaz, Bulent Mutlu, Bedrettin Yildizeli

{"title":"Prone Positioning for Acute Respiratory Failure after PEA: An Initial Experience.","authors":"Koray Ak, Majd Tarazi, Fatih Öztürk, Şehnaz Olgun Yıldızeli, Alper Kararmaz, Bulent Mutlu, Bedrettin Yildizeli","doi":"10.1055/a-2508-0644","DOIUrl":"10.1055/a-2508-0644","url":null,"abstract":"We retrospectively analyzed patients who underwent prone positioning (PP) for acute respiratory failure after pulmonary endarterectomy (PEA).A total of 125 patients underwent PEA and the outcome related to patients who underwent PP for acute respiratory failure after surgery was analyzed.In all 13 patients (10%) underwent PP at the mean duration of 28.2 ± 10.6 hours after surgery and the mean prone time was 29.4 ± 9.8 hours. Compared with the pre-prone values, there was a significant improvement in the mean arterial oxygen to fraction of inspired oxygen ratio at the end of PP (119.4 ± 12.4 versus 202 ± 58.3) (p = 0.0002). Eight patients (61%) revealed a significant improvement in oxygenation with PP. Five patients who remained unresponsive underwent extracorporeal membrane oxygenation and four of them were weaned off successfully. In multivariate logistic stepwise analysis, the need for a moderate inotropy (odds ratio [OR]: 3.1) and low preoperative cardiac index (OR: 0.2) were independent predictors of PP. Under PP, the most common complication was ventilator-associated pneumonia (n = 9, 70%) and PP was found to be an independent predictor of ventilator-associated pneumonia (OR: 10.3). Early mortality was seen in three patients (23%, sepsis in two and adult respiratory distress syndrome in one).In the early care of acute respiratory failure following PTE, PP may be a feasible option, despite an increased risk of ventilator-associated pneumonia. More research involving a larger sample size is necessary.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":"191-198"},"PeriodicalIF":1.4,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142886043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

High Efficacy and Low Early Mortality in High-Volume Center Tricuspid Valve Surgery. 大容量中心三尖瓣手术的高疗效和低早期死亡率。

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-04-01 Epub Date: 2023-03-07 DOI: 10.1055/a-2048-8199

Julia Götte, Armin Zittermann, René Schramm, Sabine Bleiziffer, Markus André Deutsch, André Renner, Jan F Gummert

{"title":"High Efficacy and Low Early Mortality in High-Volume Center Tricuspid Valve Surgery.","authors":"Julia Götte, Armin Zittermann, René Schramm, Sabine Bleiziffer, Markus André Deutsch, André Renner, Jan F Gummert","doi":"10.1055/a-2048-8199","DOIUrl":"10.1055/a-2048-8199","url":null,"abstract":"Isolated tricuspid valve surgery has been associated with early mortality rates of up to 10%. With rapidly emerging interventional catheter-based options, the question arises whether current technical and perioperative protocols in cardiac surgery translate into lower than previously expected mortality rates, especially when looking at data from high-volume centers.We performed a retrospective single-center analysis in 369 patients undergoing isolated tricuspid valve repair (n = 256) or replacement (n = 113) between 2009 and 2021. Surgical approaches included full sternotomy, as well as right-sided minithoracotomy. According to a recently introduced clinical risk score, patients were divided into scoring groups, and observed (O) versus expected (E) early mortality were compared. Pre- and postoperative tricuspid valve function was also analyzed.Overall, 30-day mortality was 4.1%, ranging from 0% (scoring group 0-1 points) to 8.7% (scoring group ≥ 10 points), which was substantially lower than the expected early mortality (2% in the lowest to 34% in the highest scoring group). Preoperative tricuspid regurgitation was severe in 71.3% (n = 263), moderate to severe in 14.9% (n = 55), and mild or less in 6.5% (n = 24). The corresponding postoperative values were 0% (n = 0), 1.4% (n = 5), and 81.6% (n = 301).Our high-volume center data indicate substantially lower than predicted 30-day mortality in different cardiac surgical risk scoring groups. The majority of patients had zero to minimal residual tricuspid valve insufficiency postoperatively. Randomized controlled trials are needed to compare tricuspid valve functional results and long-term outcomes of surgical versus interventional procedures in patients undergoing isolated tricuspid valve procedures.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":"232-238"},"PeriodicalIF":1.4,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13012843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9326314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Outcome of Emergency Pulmonary Lobectomy under ECMO Support in Patients with COVID-19. ECMO支持下急诊肺叶切除术治疗COVID-19患者的疗效

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-04-01 Epub Date: 2023-07-03 DOI: 10.1055/s-0043-1770738

Ana Beatriz Almeida, Michael Schweigert, Peter Spieth, Attila Dubecz, Marcelo Gama de Abreu, Torsten Richter, Patrick Kellner

{"title":"Outcome of Emergency Pulmonary Lobectomy under ECMO Support in Patients with COVID-19.","authors":"Ana Beatriz Almeida, Michael Schweigert, Peter Spieth, Attila Dubecz, Marcelo Gama de Abreu, Torsten Richter, Patrick Kellner","doi":"10.1055/s-0043-1770738","DOIUrl":"10.1055/s-0043-1770738","url":null,"abstract":"Not much is known about the results of nonelective anatomical lung resections in coronavirus disease 2019 (COVID-19) patients put on extracorporeal membrane oxygenation (ECMO). The aim of this study was to analyze the outcome of lobectomy under ECMO support in patients with acute respiratory failure due to severe COVID-19.All COVID-19 patients undergoing anatomical lung resection with ECMO support at a German university hospital were included into a prospective database. Study period was April 1, 2020, to April 30, 2021 (first, second, and third waves in Germany).A total of nine patients (median age 61 years, interquartile range 10 years) were included. There was virtually no preexisting comorbidity (median Charlson score of comorbidity 0.2). The mean interval between first positive COVID-19 test and surgery was 21.9 days. Clinical symptoms at the time of surgery were sepsis (nine of nine), respiratory failure (nine of nine), acute renal failure (five of nine), pleural empyema (five of nine), lung artery embolism (four of nine), and pneumothorax (two of nine). Mean intensive care unit (ICU) and ECMO days before surgery were 15.4 and 6, respectively. Indications for surgery were bacterial superinfection with lung abscess formation and progressive septic shock (seven of nine) and abscess formation with massive pulmonary hemorrhage into the abscess cavity (two of nine). All patients were under venovenous ECMO with femoral-jugular configuration. Operative procedures were lobectomy (eight) and pneumonectomy (one). Weaning from ECMO was successful in four of nine. In-hospital mortality was five of nine. Mean total ECMO days were 10.3 ± 6.2 and mean total ICU days were 27.7 ± 9.9. Mean length of stay was 28.7 ± 8.8 days.Emergency surgery under ECMO support seems to open up a perspective for surgical source control in COVID-19 patients with bacterial superinfection and localized pulmonary abscess.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":"264-272"},"PeriodicalIF":1.4,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13012836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9749622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Urgent Endovascular Aortic Repair Requiring Coverage of the Left Subclavian Artery. 需要覆盖左锁骨下动脉的血管内主动脉紧急修复。

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-04-01 Epub Date: 2023-07-07 DOI: 10.1055/a-2125-3173

Peter L Haldenwang, Christoph Heute, Karla J Schero, Markus Schlömicher, Lorine Haeuser, Volkmar Nicolas, Justus T Strauch

{"title":"Urgent Endovascular Aortic Repair Requiring Coverage of the Left Subclavian Artery.","authors":"Peter L Haldenwang, Christoph Heute, Karla J Schero, Markus Schlömicher, Lorine Haeuser, Volkmar Nicolas, Justus T Strauch","doi":"10.1055/a-2125-3173","DOIUrl":"10.1055/a-2125-3173","url":null,"abstract":"Evaluation of the optimal left subclavian artery (LSA) management during thoracic endovascular aortic repair (TEVAR) involving the distal aortic arch in an urgent setting.A total of 52 patients with acute aortic syndromes underwent TEVAR (March 2017 to May 2021) requiring proximal landing in the distal aortic arch. Decision for partial or complete LSA ostial endograft coverage, with or without additional bypassing, was made depending upon the aortic pathology and vascular anatomy. We focused on the patency of the circle of Willis and the unilateral dominance of one carotid or a vertebral artery: 35% underwent complete (complete LSA group) and 17% partial LSA coverage (partial LSA group), whereas in 48% the LSA was reached only by the bare springs of the endograft (control group). A total of 22% of the complete LSA group underwent LSA bypass before TEVAR, whereas 11% underwent cerebrospinal fluid drainage. Endpoints were 30-day and 1-year mortality, stroke, spinal cord ischemia (SCI), and malperfusion.Technical success was achieved in 96%. The endograft length was 171 ± 34 (complete LSA group) versus 151 ± 22 (partial LSA group) versus 181 ± 52 mm (control group), covering 6 ± 2 versus 5 ± 1 versus 7 ± 2 intercostal arteries. The 30-day mortality, stroke and SCI rates did not differ. One patient with arm malperfusion underwent LSA bypass post-TEVAR. After 1 year, aortic interventions occurred in 6 (complete LSA group) versus 22 (partial LSA group) versus 13% (control group). One-year mortality (0 vs. 0 vs. 8%), stroke (6 vs. 0 vs. 4%), and SCI (0 vs. 0 vs. 4%) were similar between groups.With an adequate analysis of vascular anatomy, coverage of the LSA for TEVAR is safe and may offer results similar to TEVAR starting distal to the LSA.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":"239-246"},"PeriodicalIF":1.4,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10131735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Outcomes of RDAVR with Coronary Revascularization: 3-year Results from the German INCA Registry. RDAVR与冠状动脉血运重建的疗效：德国 INCA 登记的 3 年结果。

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-04-01 Epub Date: 2025-01-27 DOI: 10.1055/a-2508-0732

Aristidis Lenos, Justus T Strauch, Markus Schlömicher, Felix Fleissner, Diana M Valencia-Nunez, Jens Garbade, Roman Gottardi, Parwis Massoudy, Markus Kamler, Rizwan Malik, Gerhard Wimmer-Greinecker, Thomas Walther, Jan Gummert, Peter Bramlage, Anno Diegeler

{"title":"Outcomes of RDAVR with Coronary Revascularization: 3-year Results from the German INCA Registry.","authors":"Aristidis Lenos, Justus T Strauch, Markus Schlömicher, Felix Fleissner, Diana M Valencia-Nunez, Jens Garbade, Roman Gottardi, Parwis Massoudy, Markus Kamler, Rizwan Malik, Gerhard Wimmer-Greinecker, Thomas Walther, Jan Gummert, Peter Bramlage, Anno Diegeler","doi":"10.1055/a-2508-0732","DOIUrl":"10.1055/a-2508-0732","url":null,"abstract":"The long-term outcomes of combined rapid-deployment aortic valve replacement (RDAVR) with coronary artery bypass graft surgery (CABG) are not well explored. We report 3-year results from the INCA registry on combined RDAVR with CABG.INCA is a prospective, multicenter registry that enrolled 224 patients undergoing RDAVR with CABG at 10 cardiac institutions in Germany. Prosthetic valve hemodynamics, clinical outcomes, and quality of life (QoL) up to 3 years were assessed.The mean age of patients was 73.6 ± 6.1 years, and the mean logistic EuroSCORE was 7.8 ± 6.0%. The mean number of distal arterial and venous anastomoses was 3.13 ± 1.56, aortic cross-clamp time was 79.4 ± 24.1 minutes, cardiopulmonary bypass time was 109.6 ± 34.5 minutes, and operation time was 224.2 ± 62.7 minutes. The majority of implanted valve size was 25 mm. At baseline, 11 patients (4.9.%) had a permanent pacemaker. Postoperatively, 17 patients (7.6%) required a new pacemaker implantation (5.4% valve-related). All-cause mortality at 30 days was 2.2%, and 11.2% at 3 years. Patient QoL (SF-12v2) was significantly restored and maintained for up to 3 years (p < 0.001). Five patients (0.9%) underwent reoperation related to endocarditis. The postimplant mean gradient was 9.2 ± 3.7 at discharge and 8.9 ± 4.6 mm Hg at 3 years.Combined RDAVR with CABG procedure is safe and effective over time. It offers stable and low transvalvular gradients with satisfactory clinical outcomes at 3 years. The pacemaker rate appears to be slightly increased, with no significant clinical effect at 3 years.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":"199-209"},"PeriodicalIF":1.4,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13012840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143053693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cardiac Surgery 2025 Reviewed. 心脏外科2025回顾。

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-03-31 DOI: 10.1055/a-2835-1473

Hristo Kirov, Tulio Caldonazo, Murat Mukharyamov, Angelique Runkel, Philine Fleckenstein, Sebastian Freiburger, Thierry Siemeni, Torsten Doenst

{"title":"Cardiac Surgery 2025 Reviewed.","authors":"Hristo Kirov, Tulio Caldonazo, Murat Mukharyamov, Angelique Runkel, Philine Fleckenstein, Sebastian Freiburger, Thierry Siemeni, Torsten Doenst","doi":"10.1055/a-2835-1473","DOIUrl":"https://doi.org/10.1055/a-2835-1473","url":null,"abstract":"For the 12th consecutive time, we systematically reviewed the cardio-surgical literature for the past year, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses approach for a results-oriented summary. In 2025, the discussion on the value of randomized and observational evidence continued, showing converging results in the treatment of coronary artery disease and further diverging results in the field of invasive aortic valve therapies. Across randomized trials, meta-analyses, and registries, coronary artery bypass grafting (CABG) consistently provides superior long-term outcomes compared with percutaneous coronary intervention in complex coronary artery disease, driven primarily by sustained reductions in future myocardial infarctions. In addition, atrial fibrillation after CABG was shown to be more frequent than expected, but its long-term burden was negligible, while prolonged dual antiplatelet therapy after CABG for acute coronary syndrome offered no benefit but increased bleeding risk. The \"valve treatment arena\" in 2025 was heavily affected by the new guidelines, which clarified many aspects in mitral and tricuspid valve treatment but generated great controversy for aortic stenosis treatment. The latter was based on a reduction of the age cut-off for transcatheter aortic valve implantation to 70 years (unsupported by new data) and the selective reliance on only randomized studies (despite contradictory risk-adjusted registry evidence). Across mitral and tricuspid valve disease, publications showed improvements in symptoms and quality of life without survival benefits with transcatheter therapies and the most consistent long-term outcomes with surgery, particularly when appropriately timed and performed in experienced centers. This article summarizes publications perceived as important by us. It cannot be complete nor free of individual interpretation, but it provides up-to-date information for patient-specific decision-making.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147594936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ten-Year Outcomes of Off-Pump Bilateral IMA Grafting Versus Hybrid Coronary Revascularization. 非体外循环双侧IMA移植与混合型冠状动脉血运重建术的10年疗效。

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-03-30 DOI: 10.1055/a-2839-7647

Ibrahim Gadelkarim, Jagdip Kang, Philipp Kiefer, Alexey Dashkevich, Piroze Davierwala, David Holzhey, Sussane de Waha, Michael Borger, Alexander Verevkin

{"title":"Ten-Year Outcomes of Off-Pump Bilateral IMA Grafting Versus Hybrid Coronary Revascularization.","authors":"Ibrahim Gadelkarim, Jagdip Kang, Philipp Kiefer, Alexey Dashkevich, Piroze Davierwala, David Holzhey, Sussane de Waha, Michael Borger, Alexander Verevkin","doi":"10.1055/a-2839-7647","DOIUrl":"https://doi.org/10.1055/a-2839-7647","url":null,"abstract":"Background The study compared long-term outcomes between off-pump coronary artery bypass grafting (OPCAB) using bilateral internal mammary arteries (BIMA) and hybrid coronary revascularization (HCR). Methods We included patients who underwent OPCAB with BIMA (2002 - 2012) and HCR (2002 - 2020). Emergency procedures, patients in critical preoperative condition, and on-pump surgery cases were excluded. Propensity score matching with a 2:1 ratio was performed to minimize confounding factors. The primary outcome was 10-year survival. Results Of 687 patients, 552 patients underwent OPCAB with BIMA and 135 patients received HCR. HCR patients were older (62 vs. 69 years, p<0.001), had lower left ventricular ejection fraction (60% vs. 54%, p<0.001), and a lower incidence of left-main disease (25% vs. 10%, p<0.001) and three-vessel disease (62.5% vs. 47.4%, p=0.002). In-hospital mortality was comparable between groups (BIMA 1.1% vs. HCR 3.0%, p=0.11). The HCR group had higher rates of incomplete revascularization (27.2% vs. 15.2%, p=0.001) and revision for bleeding (6.7% vs. 1.8%, p=0.005). After propensity score matching, 10-year survival (BIMA 71.2% vs. HCR 69.7%, p=0.81) was similar between groups, while freedom from repeat revascularization was higher in the BIMA group (89.7% vs. 76.3%, p=0.003). Conclusion Complete surgical revascularization using BIMA should be preferred when feasible. However, HCR offers comparable survival and represents a viable option for select patients.","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147582051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Technical Modifications to the Y-Incision Aortic Annular Enlargement Technique. y型切口主动脉环扩大术的技术改进。

IF 1.4 4区医学

Thoracic and Cardiovascular Surgeon Pub Date : 2026-03-26 DOI: 10.1055/a-2836-2224

Amine Fikani, Victor Jebara

引用次数: 0